| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.35 | 9e-12 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.37 | 2e-11 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |